Trial Profile
One-, Three-, Five- and Ten-Year Data on the Long-Term Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) in Adolescents 11-14 Years of Age
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2016
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 15 Mar 2016 New trial record